Yale Medicine Interventional Immunology (Rheumatology) Center

Yale Medicine Interventional Immunology (Rheumatology) Center is a leading health institution located in North Haven, Connecticut, United States. Patients at this center receive care from world-renowned doctors who specialize in rheumatology and immunology. The center offers cutting-edge treatments and therapies for a variety of autoimmune diseases and conditions.

Recently, the FDA approved Rezdiffra, the first drug for NASH, a form of fatty liver disease, which is just one example of the innovative treatments available at Yale Medicine. Additionally, cardiologists may prescribe Semaglutide (Wegovy) to help with weight loss and obesity-related conditions. The center also offers information on how anti-obesity medications can assist with surgery and recovery.

If you are seeking expert care for rheumatological or immunological conditions, consider choosing Yale Medicine Interventional Immunology (Rheumatology) Center for your healthcare needs.